These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 12353197

  • 1. An investigation of the steady-state pharmacokinetics of oral valacyclovir in immunocompromised children.
    Nadal D, Leverger G, Sokal EM, Floret D, Perel Y, Leibundgut K, Weller S.
    J Infect Dis; 2002 Oct 15; 186 Suppl 1():S123-30. PubMed ID: 12353197
    [Abstract] [Full Text] [Related]

  • 2. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
    Eisen D, Essell J, Broun ER, Sigmund D, DeVoe M.
    Bone Marrow Transplant; 2003 Jan 15; 31(1):51-5. PubMed ID: 12621507
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age.
    Kimberlin DW, Jacobs RF, Weller S, van der Walt JS, Heitman CK, Man CY, Bradley JS.
    Clin Infect Dis; 2010 Jan 15; 50(2):221-8. PubMed ID: 20014952
    [Abstract] [Full Text] [Related]

  • 4. Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection.
    Bras AP, Sitar DS, Aoki FY.
    Can J Clin Pharmacol; 2001 Jan 15; 8(4):207-11. PubMed ID: 11743593
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy: can intravenous acyclovir be substituted by oral valacyclovir?
    Eksborg S, Pal N, Kalin M, Palm C, Söderhäll S.
    Med Pediatr Oncol; 2002 Apr 15; 38(4):240-6. PubMed ID: 11920787
    [Abstract] [Full Text] [Related]

  • 6. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK, Baker D, Snowden W.
    J Infect Dis; 2002 Oct 15; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Valacyclovir and acyclovir pharmacokinetics in immunocompromised children.
    Bomgaars L, Thompson P, Berg S, Serabe B, Aleksic A, Blaney S.
    Pediatr Blood Cancer; 2008 Oct 15; 51(4):504-8. PubMed ID: 18561175
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation.
    Dignani MC, Mykietiuk A, Michelet M, Intile D, Mammana L, Desmery P, Milone G, Pavlovsky S.
    Bone Marrow Transplant; 2002 Feb 15; 29(3):263-7. PubMed ID: 11859400
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses.
    Garré B, Shebany K, Gryspeerdt A, Baert K, van der Meulen K, Nauwynck H, Deprez P, De Backer P, Croubels S.
    Antimicrob Agents Chemother; 2007 Dec 15; 51(12):4308-14. PubMed ID: 17846132
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of valacyclovir in the adult horse.
    Maxwell LK, Bentz BG, Bourne DW, Erkert RS.
    J Vet Pharmacol Ther; 2008 Aug 15; 31(4):312-20. PubMed ID: 18638291
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of a single oral dose of acyclovir and valacyclovir in North American box turtles (Terrapene sp.).
    Allender MC, Mitchell MA, Yarborough J, Cox S.
    J Vet Pharmacol Ther; 2013 Apr 15; 36(2):205-8. PubMed ID: 22670633
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study.
    Miserocchi E, Modorati G, Galli L, Rama P.
    Am J Ophthalmol; 2007 Oct 15; 144(4):547-51. PubMed ID: 17692271
    [Abstract] [Full Text] [Related]

  • 19. Multiple oral dosing of valacyclovir in horses and ponies.
    Garré B, Baert K, Nauwynck H, Deprez P, De Backer P, Croubels S.
    J Vet Pharmacol Ther; 2009 Jun 15; 32(3):207-12. PubMed ID: 19646083
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy.
    Kimberlin DF, Weller S, Whitley RJ, Andrews WW, Hauth JC, Lakeman F, Miller G.
    Am J Obstet Gynecol; 1998 Oct 15; 179(4):846-51. PubMed ID: 9790357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.